These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 11029994)

  • 41. The impact of prostate cancer knowledge on cancer screening.
    Weinrich SP; Weinrich MC; Boyd MD; Atkinson C
    Oncol Nurs Forum; 1998 Apr; 25(3):527-34. PubMed ID: 9568607
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Does evidence-based information about screening for prostate cancer enhance consumer decision-making? A randomised controlled trial.
    Gattellari M; Ward JE
    J Med Screen; 2003; 10(1):27-39. PubMed ID: 12790313
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prostate specific antigen testing and digital rectal examination before and during a randomized trial of screening for prostate cancer: European randomized study of screening for prostate cancer, Rotterdam.
    Beemsterboer PM; de Koning HJ; Kranse R; Trienekens PH; van der Maas PJ; Schröder FH
    J Urol; 2000 Oct; 164(4):1216-20. PubMed ID: 10992369
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Factors affecting prostate cancer screening behaviour in a discrete population of doctors at the University Hospital of the West Indies, Jamaica.
    McNaughton D; Aiken W; McGrowder D
    Asian Pac J Cancer Prev; 2011; 12(5):1201-5. PubMed ID: 21875267
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prostate cancer detection by using digital rectal examination: contemporary practice patterns in the United States.
    Tourville EA; Nguyen MM
    Clin Genitourin Cancer; 2013 Sep; 11(3):263-9. PubMed ID: 23647941
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Knowledge, attitudes, and practices towards prostate cancer screening amongst men living in the southern Italian peninsula: the Prevention and Research in Oncology (PRO) non-profit Foundation experience.
    Mirone V; Imbimbo C; Arcaniolo D; Franco M; La Rocca R; Venturino L; Spirito L; Creta M; Verze P
    World J Urol; 2017 Dec; 35(12):1857-1862. PubMed ID: 28780740
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prostate cancer testing: behaviour, motivation and attitudes among Western Australian men.
    Slevin TJ; Donnelly N; Clarkson JP; English DR; Ward JE
    Med J Aust; 1999 Aug; 171(4):185-8. PubMed ID: 10494233
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Men's knowledge and attitudes towards dietary prevention of a prostate cancer diagnosis: a qualitative study.
    Horwood JP; Avery KN; Metcalfe C; Donovan JL; Hamdy FC; Neal DE; Lane JA
    BMC Cancer; 2014 Nov; 14():812. PubMed ID: 25374269
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Economic Analysis.
    Tawfik A
    Ont Health Technol Assess Ser; 2015; 15(11):1-37. PubMed ID: 26366237
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Knowledge, beliefs, and prior screening behavior among blacks and whites reporting for prostate cancer screening.
    Demark-Wahnefried W; Strigo T; Catoe K; Conaway M; Brunetti M; Rimer BK; Robertson CN
    Urology; 1995 Sep; 46(3):346-51. PubMed ID: 7660510
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening.
    Catalona WJ; Smith DS; Ratliff TL; Basler JW
    JAMA; 1993 Aug; 270(8):948-54. PubMed ID: 7688438
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cancer worry is associated with abnormal prostate-specific antigen levels in men participating in a community screening program.
    Cohen L; Fouladi RT; Babaian RJ; Bhadkamkar VA; Parker PA; Taylor CC; Smith MA; Gritz ER; Basen-Engquist K
    Cancer Epidemiol Biomarkers Prev; 2003 Jul; 12(7):610-7. PubMed ID: 12869399
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A community-based intervention to promote informed decision making for prostate cancer screening among Hispanic American men changed knowledge and role preferences: a cluster RCT.
    Chan EC; McFall SL; Byrd TL; Mullen PD; Volk RJ; Ureda J; Calderon-Mora J; Morales P; Valdes A; Kay Bartholomew L
    Patient Educ Couns; 2011 Aug; 84(2):e44-51. PubMed ID: 21237611
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prostate-specific antigen screening in elderly men.
    Lu-Yao G; Stukel TA; Yao SL
    J Natl Cancer Inst; 2003 Dec; 95(23):1792-7. PubMed ID: 14652241
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The influence of physician recommendation on prostate-specific antigen screening.
    Pucheril D; Dalela D; Sammon J; Sood A; Sun M; Trinh QD; Menon M; Abdollah F
    Urol Oncol; 2015 Oct; 33(10):424.e1-7. PubMed ID: 26206103
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Factors influencing use of the prostate-specific antigen screening test in primary care.
    Moran WP; Cohen SJ; Preisser JS; Wofford JL; Shelton BJ; McClatchey MW
    Am J Manag Care; 2000 Mar; 6(3):315-24. PubMed ID: 10977432
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prostate-specific antigen screening in a high-risk population: lessons from the community and how they relate to large-scale population-based studies.
    Shelton JB; Barocas DA; Conway F; Hart K; Nelson K; Richstone L; Gonzalez RR; Raman JD; Scherr DS
    Urology; 2005 May; 65(5):931-6. PubMed ID: 15882726
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
    Pinsky PF; Blacka A; Kramer BS; Miller A; Prorok PC; Berg C
    Clin Trials; 2010 Aug; 7(4):303-11. PubMed ID: 20571134
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differentiation of the health behavior patterns related to prostate cancer screening among African-American men in military settings.
    Edwards QT; Johnson CG; Mason S; Boyle G
    Mil Med; 2002 May; 167(5):374-8. PubMed ID: 12053844
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prostate cancer screening in Portugal: prevalence and perception of potential benefits and adverse effects.
    Braga R; Costa AR; Pina F; Moura-Ferreira P; Lunet N
    Eur J Cancer Prev; 2020 May; 29(3):248-251. PubMed ID: 31651568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.